ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast of Editas Medicine Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Editas Medicine EDIT at this time. Stock is rising and might rise more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!

My analysis of Editas Medicine is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Editas Medicine stays above 3.1, but if it comes below 3.1, then a intra day sell could be more profitable.
If you take a sell trade below 3.1, then use 3.1 as stoploss and 2.89 as target. However if you take a buy trade in Editas Medicine, then use 3.1 as stoploss and 3.2 as target.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

Wave of mass market credit cards erodes foreign majors’ base Standard Chartered and DBS Bank India recorded the sharpest contractions. The former's card base fell 28% to 581,000, a fall of 227,000 cards, while expenditure fell nearly 18% to Rs 693 crore in June. DBS' India portfolio contracted 29% to 310,000 cards, - NEWS as on 2026-08-24 indiatimes.com

Gold loans' share of system credit could reach 10% in 5 years: JP Morgan Gold loans could gain from a structural shift towards monetising household gold, lower borrowing costs and rising financial literacy, with penetration remaining relatively low - NEWS as on 2026-08-21 business-standard.com

Punjab National Bank inks pact with Indian Army to offer curated credit cards to army personnel Punjab National Bank and the Indian Army have signed an exclusive memorandum of understanding. This partnership will offer two specialised credit cards for Army personnel. These cards provide benefits like cashback and airport lounge access. The PNB Par - NEWS as on 2026-08-21 indiatimes.com

India's credit footprint expands as new states emerge as growth centres Credit growth is shifting from traditional strongholds such as Tamil Nadu and Maharashtra towards Uttar Pradesh, Bihar and Madhya Pradesh, but penetration still trails developed markets - NEWS as on 2026-08-21 business-standard.com

Private credit deals drop 61 pc to USD 3.5 bn in H1 2026: Report Private credit deployments saw a sharp 61 percent drop in early 2026. This decline occurred amid a volatile macro economic environment and shifting fund dynamics. Domestic funds led nearly three-fourths of the deployments during this period. Real estate - NEWS as on 2026-08-20 indiatimes.com

Local funds' share rises in private credit market: EY report Private credit investments were broadly similar to the second half of 2025 levels of .4 billion, with refinancing, holding-company funding and acquisition financing serving as key drivers of activity. "The growing share of domestic capital is one of the - NEWS as on 2026-08-20 indiatimes.com

Axis Bank credit card rules change: What gets costlier from Aug 28 From higher overseas transaction costs to revised late fees and reward exclusions, Axis Bank cardholders face several changes from August 28 - NEWS as on 2026-08-19 business-standard.com

Godrej Industries to enter pvt credit space, aims to raise ?2,000 cr in AIF Godrej Industries Group (GIG) on Tuesday announced an entry into the private credit space, targeting to raise up to Rs 2,000 crore in maiden alternate investment fund (AIF). In an announcement that comes days after Pirojsha Godrej from the next generation - NEWS as on 2026-08-18 business-standard.com

FIDC to flag NBFC concerns over RBI's proposed revolving credit ban The industry body is collating views from NBFCs before submitting feedback to the RBI, with lenders warning that the proposed restriction could favour banks - NEWS as on 2026-08-17 business-standard.com

India sees sharp expansion in retail, MSME credit access since 2021 Retail bureau coverage rose 1.7 times to 78.9 crore borrowers by 2026, while active MSME borrowers more than doubled to 1.9 crore over the five-year period - NEWS as on 2026-08-14 business-standard.com

Motilal Oswal commits Rs 1,500 crore to Inox Clean in hybrid private credit deal Motilal Oswal Group has committed Rs 1,500 crore to Inox Clean Energy Ltd through compulsorily convertible debentures to fund acquisitions and growth. The initial Rs 1,000 crore has been deployed, with the remaining Rs 500 crore expected soon. This hybrid - NEWS as on 2026-08-13 indiatimes.com

Sebi proposes mandatory 'Credit Risk-o-Meter' for debt securities Under the proposal, issuers and online bond platform providers (OBPPs) would be required to display the Credit Risk-o-Meter in offer documents, abridged prospectuses, private placement memorandums - NEWS as on 2026-08-13 business-standard.com

Bank of America to acquire 49.9% in Jio Credit in potential Rs 18,268 crore deal Jio Financial Services and Bank of America announced a significant joint venture agreement. The US banking major will acquire up to 49.9% in Jio Credit. This investment could reach Rs 18,268 crore, approximately .9 billion. Bank of America will initia - NEWS as on 2026-08-12 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 3
  • 12Day Average: 2.92
  • 20Day Average: 2.82
  • 50Day Average: 2.91
  • 100Day Average: 2.94
  • 150Day Average: 2.67
  • 200Day Average: 2.59

EDIT Indicators & signals

Indicator MACD (12,26,9)

2.92, 2.89, -0.01
Indicator MACD is in positive zone

Indicator ADX (14)

0, 29.17, 29.17
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
21 Fri Aug 2026 3.11 2.95 to 3.25 6.51% 0.83 times
20 Thu Aug 2026 2.92 2.92 to 3.26 -10.15% 1.45 times
19 Wed Aug 2026 3.25 2.75 to 3.30 12.46% 3.53 times
18 Tue Aug 2026 2.89 2.79 to 2.99 1.76% 0.74 times
17 Mon Aug 2026 2.84 2.77 to 2.89 0.71% 0.83 times
14 Fri Aug 2026 2.82 2.72 to 2.85 0% 0.58 times
13 Thu Aug 2026 2.82 2.81 to 2.90 -0.7% 0.36 times
12 Wed Aug 2026 2.84 2.82 to 3.03 -3.73% 0.64 times
11 Tue Aug 2026 2.95 2.83 to 2.99 4.98% 0.75 times
10 Mon Aug 2026 2.81 2.79 to 2.90 -2.43% 0.58 times
07 Fri Aug 2026 2.88 2.87 to 3.09 -1.03% 0.53 times
06 Thu Aug 2026 2.91 2.78 to 3.14 5.82% 1.15 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top